Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta‐analysis
European Journal of Clinical Investigation · 2025-05 · 55 (5)
DOI: 10.1111/eci.14388 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 22.01.2025. Verfasst von Kamil Stankowski und 13 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. Hauptthemen laut MEDLINE: Fabry Disease, Cardiomyopathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Cardiac involvement represents the main cause of death in patients with Fabry disease (FD). Echocardiography and cardiovascular magnetic resonance (CMR) have an established diagnostic role, but their prognostic value remains unresolved. This systematic review and meta‐analysis sought to assess the prognostic implications of imaging parameters in FD.
Methods
PubMed, ClinicalTrials.gov , Embase, Cochrane Library and Web of Science databases were searched for studies from inception through 1 May 2024. Studies including FD patients undergoing baseline imaging assessment and clinical follow‐up were selected. Pre‐defined study outcomes were a cardiovascular endpoint and a composite clinical endpoint. The study protocol was registered in PROSPERO (ID CRD42022342394).
Results
Fourteen studies, including 1713 FD patients (44.7% males), were selected. At pooled analysis, late gadolinium enhancement (hazard ratio [HR]: 4.45; 95% CI: 2.82–7.02), left atrium volume indexed (HR: 1.02 per mL/m 2 ; 95% CI: 1.01–1.03), E/e′ (HR: 1.14 per unit increase; 95% CI: 1.08–1.21), left ventricular (LV) mass indexed (HR: 1.01 per mg/m 2 ; 95% CI: 1.00–1.02), maximum LV wall thickness (HR: 1.19 per mm, 95% CI: 1.04–1.36) and LV‐global longitudinal strain (HR: 1.20 per unit increase; 95% CI: 1.16–1.25) were significantly associated with the cardiovascular endpoint, whereas T1‐mapping and LV‐ejection fraction were not. T1‐mapping was associated with the composite endpoint (HR: 0.99 per msec increase; 95% CI: 0.98–1.00). Meta‐regression analysis did not show any significant interaction between each of the potential effect modifiers.
Conclusions
Several imaging parameters were significant predictors of adverse clinical outcomes in patients with FD. Late gadolinium enhancement showed the strongest association with adverse prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
- School of Medicine, University of Nottingham, Nottingham, UK.
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
- School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
- Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
ORCID-Profile: Stefano Figliozzi, Georgios Georgiopoulos
Zitieren
APA
Stankowski, K., Figliozzi, S., Rojanathagoon, T., Bampatsias, D., Klettas, D., Monti, L., Bragato, R., Masci, P. G., Francone, M., Condorelli, G., Imbriaco, M., Pieroni, M., Camporeale, A., & Georgiopoulos, G. (2025). Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta‐analysis. European Journal of Clinical Investigation, 55(5). https://doi.org/10.1111/eci.14388
Vancouver
Stankowski K, Figliozzi S, Rojanathagoon T, Bampatsias D, Klettas D, Monti L, et al. Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta‐analysis. European Journal of Clinical Investigation. 2025;55(5). doi:10.1111/eci.14388
BibTeX
@article{Stankowski2025,
author = {Stankowski, Kamil and Figliozzi, Stefano and Rojanathagoon, Thanakorn and Bampatsias, Dimitrios and Klettas, Dimitrios and Monti, Lorenzo and Bragato, Renato and Masci, Pier-Giorgio and Francone, Marco and Condorelli, Gianluigi and Imbriaco, Massimo and Pieroni, Maurizio and Camporeale, Antonia and Georgiopoulos, Georgios},
title = {Imaging predictors of adverse prognosis in Fabry disease cardiomyopathy: A systematic review and meta‐analysis},
journal = {European Journal of Clinical Investigation},
year = {2025},
volume = {55},
number = {5},
doi = {10.1111/eci.14388}
}
EUVIMED